Paxlovid does not increase risk of COVID reinfection: study

Dilated Ureter May Up UTI Risk in Kids With Hydronephrosis

Dilation of the ureter is linked to an increased risk for urinary tract infections in children with prenatal hydronephrosis.

COVID History May Prompt New Allergies

Data from a large study of children and adults showed an increased risk of developing atopic diseases in those with a history of SARS-CoV-2 infection.

Allowing Rotavirus Vaccination in NICU May Boost Coverage

ACIP guidelines currently say rotavirus vaccination should not be administered before NICU discharge, but study authors say that’s contributing to poor coverage.

Celiac Disease and Antibiotic Use: Is There a Causal Link?

A recent study suggests that the link between antibiotic use and celiac disease may reflect increased testing and not causation.

Psilocybin Shows Benefit in Real-World TRD

One of the first real-world studies of psilocybin therapy suggests meaningful improvements in treatment-resistant depression outside the controlled setting of clinical trials.

Antihistamines Not Tied to Dementia Risk in Allergic Disease

The use of second-generation antihistamines is not linked to a higher risk of developing dementia in patients with chronic urticaria, chronic sinusitis, or allergic rhinitis, a real-world study shows.

ACOG Issues Simplified Maternal Vaccine Schedule

The organization says it aims for clarity for its members and to dispel misinformation.

Adding Dexamethasone to ONB Offers No Benefit in Headache

Adding dexamethasone to occipital nerve block offered no additional reduction in headache days compared to ONB alone, a new randomized controlled trial shows.

IBS and Physical Activity: What’s the Link?

Higher levels of Fitbit-recorded physical activity are linked to lower odds of irritable bowel syndrome, whereas greater sedentary time is linked to higher odds of the condition.

Patient-Reported QoL Offers Prognostic Information in AML

The pretreatment evaluation of patient-reported, health-related quality of life provides valuable prognostic information on overall survival beyond genetic and clinical data.

ctDNA Can Predict Relapse, but Should Oncologists Act On It?

As ctDNA moves into clinical practice, oncologists across specialties are grappling with whether and how to use the results to guide treatment decisions.

The Obesity Paradox: High in Calories, Low in Nutrients

Beyond Laxatives: Emerging Ways to Manage Constipation

In this Medscape podcast, Dr Benjamin Levy interviews Dr Darren Brenner about modern constipation management, including pelvic floor dysfunction, motility testing, and nonpharmacologic therapies.

Frontline Serplulimab Extends Survival in SCLC

Four-year follow-up from the ASTRUM-005 trial shows durable survival benefits with first-line serplulimab plus chemotherapy in extensive-stage SCLC.

Scotland Backs Bispecific Antibody for Refractory Myeloma

The SMC accepted talquetamab for relapsed and refractory multiple myeloma, offering eligible patients in Scotland a new option after multiple prior therapies.

New Data Support Medication Switch in Select MS Patients

For patients experiencing increased rates of infection or adverse events on anti-CD20 therapy, switching to a less immunosuppressive option may be a safe option, data show.